Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524–33. https://doi.org/10.1038/s41586-021-03392-8.

Article  PubMed  CAS  Google Scholar 

Björkegren JLM, Lusis AJ. Atherosclerosis: recent developments. Cell. 2022;185:1630–45. https://doi.org/10.1016/j.cell.2022.04.004.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tamargo IA, Baek KI, Kim Y, Park C, Jo H. Flow-induced reprogramming of endothelial cells in atherosclerosis. Nat Rev Cardiol. 2023;20:738–53. https://doi.org/10.1038/s41569-023-00883-1.

Article  PubMed  Google Scholar 

Kondreddy V, et al. Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1. Blood. 2018;131:2379–92. https://doi.org/10.1182/blood-2017-10-813527.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kondreddy V, et al. The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis. Blood. 2022;140:1549–64. https://doi.org/10.1182/blood.2022016424.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lau ES, et al. Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction. Nat Commun. 2023;14:7557.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fredman G, Serhan CN. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024;21:808–23. https://doi.org/10.1038/s41569-023-00984-x.

Article  PubMed  Google Scholar 

Norris PC, Gosselin D, Reichart D, Glass CK, Dennis EA. Phospholipase A2 regulates eicosanoid class switching during inflammasome activation. Proc Natl Acad Sci. 2014;111:12746–51. https://doi.org/10.1073/pnas.1404372111.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Gijón MA, Riekhof WR, Zarini S, Murphy RC, Voelker DR. Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J Biol Chem. 2008;283:30235–45. https://doi.org/10.1074/jbc.M806194200.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hishikawa D, et al. Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc Natl Acad Sci. 2008;105:2830–5. https://doi.org/10.1073/pnas.0712245105.

Article  PubMed  PubMed Central  Google Scholar 

Zhao Y, et al. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase. J Biol Chem. 2008;283:8258–65. https://doi.org/10.1074/jbc.M710422200.

Article  PubMed  CAS  Google Scholar 

Kondreddy V, Banerjee R, Devi B, Muralidharan K, Piramanayagam S. Inhibition of the MALT1-LPCAT3 axis protects cartilage degeneration and osteoarthritis. Cell Commun Signal. 2024;22:189. https://doi.org/10.1186/s12964-024-01547-4.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rong X, et al. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. Elife. 2015;4:e06557. https://doi.org/10.7554/eLife.06557.

Article  PubMed  PubMed Central  Google Scholar 

Koeberle A, et al. Arachidonoyl-phosphatidylcholine oscillates during the cell cycle and counteracts proliferation by suppressing Akt membrane binding. Proc Natl Acad Sci USA. 2013;110:2546–51. https://doi.org/10.1073/pnas.1216182110.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka H, et al. Lysophosphatidylcholine acyltransferase-3 expression is associated with atherosclerosis progression. J Vasc Res. 2017;54:200–8. https://doi.org/10.1159/000473879.

Article  PubMed  CAS  Google Scholar 

Shao G, et al. Research progress in the role and mechanism of LPCAT3 in metabolic related diseases and cancer. J Cancer. 2022;13:2430–9. https://doi.org/10.7150/jca.71619.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jiang H, Li Z, Huan C, Jiang XC. Macrophage lysophosphatidylcholine acyltransferase 3 deficiency-mediated inflammation is not sufficient to induce atherosclerosis in a mouse model. Front Cardiovasc Med. 2018;5:192. https://doi.org/10.3389/fcvm.2018.00192.

Article  PubMed  CAS  Google Scholar 

Hashidate-Yoshida T, et al. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport. Elife. 2015;4:e06328. https://doi.org/10.7554/eLife.06328.

Article  PubMed  PubMed Central  Google Scholar 

Bourgeois T, et al. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet. J Lipid Res. 2021;62:100013. https://doi.org/10.1194/jlr.RA120000737.

Article  PubMed  CAS  Google Scholar 

Li Z, et al. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice. Gastroenterology. 2015;149:1519–29. https://doi.org/10.1053/j.gastro.2015.07.012.

Article  PubMed  CAS  Google Scholar 

Ferrara PJ et al. Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle. J Clin Invest. 2021;131. https://doi.org/10.1172/jci135963.

Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of CANTOS and beyond. J Am Coll Cardiol. 2017;70:2278–89. https://doi.org/10.1016/j.jacc.2017.09.028.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mai W, Liao Y. Targeting IL-1β in the treatment of atherosclerosis. Front Immunol. 2020;11:589654. https://doi.org/10.3389/fimmu.2020.589654.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kondreddy V, Magisetty J, Keshava S, Rao LVM, Pendurthi UR. Gab2 (Grb2-associated Binder2) plays a crucial role in inflammatory signaling and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2021;41:1987–2005. https://doi.org/10.1161/ATVBAHA.121.316153.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Guzik TJ, Nosalski R, Maffia P, Drummond GR. Immune and inflammatory mechanisms in hypertension. Nat Rev Cardiol. 2024;21:396–416. https://doi.org/10.1038/s41569-023-00964-1.

Article  PubMed  CAS  Google Scholar 

Wagner DD, Heger LA. Thromboinflammation: from atherosclerosis to COVID-19. Arterioscler Thromb Vasc Biol. 2022;42:1103–12. https://doi.org/10.1161/ATVBAHA.122.317162.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Brånén L, et al. Inhibition of tumor necrosis factor-α reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2004;24:2137–42. https://doi.org/10.1161/01.ATV.0000143933.20616.1b.

Article  PubMed  CAS  Google Scholar 

Hettwer J, et al. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis. Cardiovasc Res. 2021;118:2778–91. https://doi.org/10.1093/cvr/cvab337.

Article  PubMed Central  CAS  Google Scholar